Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2005

01-05-2005 | Original Investigation

Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia

Authors: K. P. Ng, T. L. Saw, A. Baki, K. Rozainah, K. W. Pang, M. Ramanathan

Published in: Medical Microbiology and Immunology | Issue 3/2005

Login to get access

Abstract

The implementation of the Expanded Program of Immunization (EPI) in 1989 has dramatic impact on hepatitis B virus (HBV) infection in school children in Malaysia. A cross-sectional seroprevalence study of HBV infection in 190,077 school children aged 7–12 years from 1997 to 2003 showed a steady decline of HBV surfacce antigen (HBsAg) prevalence rate from 2.5% for children born in 1985 to 0.4% among school children born in 1996. The overall prevalence of HBsAg was 0.6%, 0.7% in males and 0.6% in females. Over 92.7% of school children had been vaccinated with HBV vaccine, in which 93.7% were vaccinated under the EPI and 6.3% on voluntary basis. The school children vaccinated under EPI had a 0.4% HBsAg carrier rate, which was significantly lower than school children vaccinated on a voluntary basis (HBsAg carrier rate 1.3%) and non-vaccinated school children (HBsAg carrier rate 2.7%), suggesting that HBV vaccination of infants was the most effective measure in preventing vertical transmission of HBV in the hyperendemic region.

Literature
  1. Gust ID (1996) Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38 (Suppl 2):S18–S23PubMed
  2. Campbell DH, Plant AJ, Sargent JW, Mock PA, et al (1991) Hepatitis B infection of children in a mixed-race community in western New South Wales. Med J Aust 154:253–256PubMed
  3. Guan R (1996) Hepatitis B virus infection in Singapore. Gut 38 (Suppl 2):S13–S17PubMed
  4. Ton SH, Lopez CG, Cheong KS, Noriah R (1984) Infectiousness with respect to HBV of medical staff and patients in the General Hospital, Kuala Lumpur. Singapore Med J 25:244–246PubMed
  5. Lopez CG (1985) Epidemiology of persistent hepatitis B virus infection. Malaysian J Pathol 7:7–10
  6. Beasley RP, Hwang LY (1983) Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 143:185–190
  7. Stevens CE, Neurath RA, Beasley RP, et al (1979) HBeAg and anti-HBs detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B in Taiwan. J Med Virol 3:237–241PubMed
  8. Margolis HS (1990) The road ahead—future policy for the elimination of hepatitis B transmission in the United States. Proceeding of the 24th National Immunization Conference. US Department of Health and Human Services, Washington D.C., pp 33–37
  9. Wong VCW, Ip HMH, Reesink HW, Lelie PN, Reerink-Brongers EE, et al (1984) Prevention of HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet I:921–926View Article
  10. Goh KT (1995) Acute hepatitis B survillance in Singapore. Epidemiol News Bull 21:33–34
  11. Tsen YJ, Chang MN, Hsu HY Y, et al (1991) Seroprevalence of hepatitis B infection in children in Taipei 1989: five years after a mass hepatitis B vaccination programme. J Med Virol 34:96–99PubMed
  12. Chen DS, Sung JL, Lai MY (1978) A seroepidemiological study of hepatitis B infection in Taiwan. J Formosa Med Assoc 77:908–918
  13. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, et al (1982) Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 146:198–204PubMed
  14. Szmuness W, Harley EJ, Ikram H, Stevens CE (1978) Sociodemographic aspects of the epidemiology of hepatitis B. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis: a contemporary assessment of etiology, epidemiology, pathogenesis and prevention. Franklin Institute Press, Philadelphia, pp 297–320
  15. Vann Mayans M, Hall AJ, Inskip HM, et al (1990) Risk factors for transmission of hepatitis B virus to Gambian children. Lancet 336:1107–1109View ArticlePubMed
  16. Gust ID, Dimitrakakis M, Zimmet P (1978) Studies of hepatitis B surface antigen and antibody in Nauru. I. Distribution among Nauruans. Am J Trop Med Hyg 27:1030–1036
  17. Milne A, Allwood GK, Moyes CD, et al (1989) Prevalence of hepatitis B infections in a multiracial New Zealand community. N Z Med J 98:529–532
  18. CDC (1988) Recommendations of the Immunization Practices Advisory Committee. Prevention of perinatal trasnsmission of hepatitis B virus. Prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR 37:341–356
  19. Margolis HS, Coleman PJ, Brown RE, Mast EE, et al (1995) Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 274:1201–1208View ArticlePubMed
Metadata
Title
Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia
Authors
K. P. Ng
T. L. Saw
A. Baki
K. Rozainah
K. W. Pang
M. Ramanathan
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2005
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-004-0231-4

Other articles of this Issue 3/2005

Medical Microbiology and Immunology 3/2005 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.